Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 699


Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.

Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, Möricke A, Henze G, von Stackelberg A; ALL-REZ BFM Study Group..

Eur J Cancer. 2008 Jan;44(2):257-68.


Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.

Tavernier E, Le QH, de Botton S, Dhédin N, Bulabois CE, Reman O, Vey N, Lhéritier V, Dombret H, Thomas X.

Cancer. 2007 Dec 15;110(12):2747-55.


Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, Schirg E, Henze G, Schellong G, Gadner H, Riehm H.

Blood. 2000 Jan 15;95(2):416-21.


Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.

Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.

Klin Padiatr. 1998 Jul-Aug;210(4):192-9.


Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.

Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A.

J Clin Oncol. 2006 Jan 20;24(3):491-9.


Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.

Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J.

Int J Hematol. 2001 Apr;73(3):369-77. Review.


Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL.

Blood. 2002 Jun 15;99(12):4257-64.


Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.

Schrappe M, Aricò M, Harbott J, Biondi A, Zimmermann M, Conter V, Reiter A, Valsecchi MG, Gadner H, Basso G, Bartram CR, Lampert F, Riehm H, Masera G.

Blood. 1998 Oct 15;92(8):2730-41.


Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H.

Blood. 2000 Jun 1;95(11):3310-22.


Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA.

J Clin Oncol. 2008 Jun 20;26(18):3046-50. doi: 10.1200/JCO.2008.16.1117.


Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.

J Clin Oncol. 2005 Nov 1;23(31):7942-50. Erratum in: J Clin Oncol. 2008 May 1;26(13):2238.


Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean National Trial PINDA 87.

Campbell M, Salgado C, Quintana J, Becker A, Vargas L, Cabrera ME, Beresi V, Rojas J, Paez E, Tapia S, Zolezzi P, Advis P.

Med Pediatr Oncol. 1999 Aug;33(2):88-94.


Second neoplasms after megavoltage radiation for pediatric tumors.

Gold DG, Neglia JP, Dusenbery KE.

Cancer. 2003 May 15;97(10):2588-96.


Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.

Stanulla M, Schaeffeler E, Möricke A, Coulthard SA, Cario G, Schrauder A, Kaatsch P, Dördelmann M, Welte K, Zimmermann M, Reiter A, Eichelbaum M, Riehm H, Schrappe M, Schwab M.

Blood. 2009 Aug 13;114(7):1314-8. doi: 10.1182/blood-2008-12-193250.


Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.

Bührer C, Henze G, Hofmann J, Reiter A, Schellong G, Riehm H.

Haematol Blood Transfus. 1990;33:500-3. Review.


Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.

Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM.

N Engl J Med. 2003 Aug 14;349(7):640-9. Erratum in: N Engl J Med. 2003 Sep 25;349(13):1299.


Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.

Attarbaschi A, Mann G, Dworzak M, Urban C, Fink FM, Dieckmann K, Riehm H, Gadner H; Austrian Cooperative Study Group..

Wien Klin Wochenschr. 2002 Feb 28;114(4):148-57.


Supplemental Content

Support Center